Article
High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology - 1 Jul 2018
Conte Giulio, Kawabata Mihoko, de Asmundis Carlo, Taravelli Erika, Petracca Francesco, Ruggiero Diego, Caputo Maria Luce, Regoli François, Chierchia Gian-Battista, Chiodini Alessandra, Del Bufalo Alessandro, Moccetti Tiziano, Goya Masahiko, Hirao Kenzo, Vicentini Alessandro, De Ferrari Gaetano M, Brugada Pedro, Auricchio Angelo
Abstract excerpt
Aims: Subcutaneous implantable cardioverter-defibrillator (S-ICD) can avoid important complications associated with transvenous leads in patients with inherited primary arrhythmia syndromes, who do not need pacing therapy. Few data are available on the percentage of patients with inherited arrhythmia syndromes eligible for S-ICD implantation. Aim of this study was to analyse the eligibility for S-ICD in a series...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.